Disc Medicine

Share on: 
Website: Disc Medicine
Business Area(s): 

Disc Medicine is a hematology company harnessing new insights in hepcidin biology to address ineffective red blood cell production (erythropoiesis) in hematologic diseases. When hepcidin levels are inappropriately high, reduced iron mobilization can impair red cell formation and lead to anemia. In contrast, when hepcidin levels are inappropriately low, increased iron uptake and mobilization can lead to tissue iron overload and exacerbate anemia.

Career Page(s): 
Cambridge MA
United States